© 2014 AMICUS SA. All rights reserved. Terms of Use. Privacy Policy
AMICUS GEOGRAPHIC AND THERAPEUTIC FOCUS While today Amicus is primarily focused on the CEE region, Amicus is anticipates to further expand to Russia / CIS countries, and later possibly to Western Europe, Middle East or Africa. That said, Amicus’ focus is in the following therapeutic areas: Modern, high tech, professionally-positioned products with a compelling medical proposition (evidence based medicine / significant clinical impact), especially in oncology/hematology, nephrology, transplantation medicines, GI and other specialty. Rare disease / orphan medicines - new, dedicated business unit formed as of December, 2018 OTCs / Open Market preferably established brands or products with Unique Selling Propositions Out of pocket / largely non-reimbursed products, in areas of critical unmet needs Products with rapid regulatory pathways: Medical Devices / Food Supplements / Cosmetics and products with existing registrations Selective Purchase of existing brands or platforms that carefully complement our partners portfolios
A Swiss Pharmaceutical Company